{"abstracts-retrieval-response": {"item": {"ait:process-info": {"ait:status": {"@state": "update", "@type": "core", "@stage": "S300"}, "ait:date-delivered": {"@day": "23", "@timestamp": "2021-02-23T14:29:42.000042-05:00", "@year": "2021", "@month": "02"}, "ait:date-sort": {"@day": "01", "@year": "2016", "@month": "08"}}, "xocs:meta": {"xocs:funding-list": {"@pui-match": "primary", "@has-funding-info": "1", "xocs:funding": [{"xocs:funding-agency-matched-string": "Ratchadaphiseksomphot Endowment Fund ofChulalongkorn University", "xocs:funding-id": "CU-57-001-HR"}, {"xocs:funding-agency-matched-string": "RatchadaphiseksomphotResearch"}, {"xocs:funding-agency-matched-string": "Chulalongkorn University", "xocs:funding-agency-acronym": "CU", "xocs:funding-agency": "Chulalongkorn University", "xocs:funding-id": "63/53", "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/501100002873", "xocs:funding-agency-country": "http://sws.geonames.org/1605651/"}], "xocs:funding-addon-generated-timestamp": "2021-05-09T04:02:12.147209Z", "xocs:funding-text": "This work was supported by a RatchadaphiseksomphotResearch Grant, Faculty of Medicine, Chulalongkorn University, Grant number 63/53 andby the Ratchadaphiseksomphot Endowment Fund ofChulalongkorn University (CU-57-001-HR).", "xocs:funding-addon-type": "http://vtw.elsevier.com/data/voc/AddOnTypes/50.7/aggregated-refined"}}, "bibrecord": {"head": {"author-group": [{"affiliation": {"country": "Thailand", "postal-code": "10330", "@afid": "60028190", "@country": "tha", "city": "Bangkok", "organization": [{"$": "Division of Medical Oncology"}, {"$": "Department of Medicine"}, {"$": "Faculty of Medicine"}, {"$": "Chulalongkorn University"}, {"$": "King Chulalongkorn Memorial Hospital"}], "affiliation-id": [{"@afid": "60028190", "@dptid": "113019942"}, {"@afid": "60022183"}], "@dptid": "113019942"}, "author": [{"ce:given-name": "Walailuk", "preferred-name": {"ce:given-name": "Walailuk", "ce:initials": "W.", "ce:surname": "Tanpipattanakul", "ce:indexed-name": "Tanpipattanakul W."}, "@seq": "1", "ce:initials": "W.", "@_fa": "true", "@type": "auth", "ce:surname": "Tanpipattanakul", "@auid": "57192099732", "ce:indexed-name": "Tanpipattanakul W."}, {"ce:given-name": "Nattaya", "preferred-name": {"ce:given-name": "Nattaya", "ce:initials": "N.", "ce:surname": "Poovorawan", "ce:indexed-name": "Poovorawan N."}, "@seq": "2", "ce:initials": "N.", "@_fa": "true", "@type": "auth", "ce:surname": "Poovorawan", "@auid": "57192107420", "ce:indexed-name": "Poovorawan N."}, {"ce:given-name": "Piyada", "preferred-name": {"ce:given-name": "Piyada", "ce:initials": "P.", "ce:surname": "Sithidetphaiboon", "ce:indexed-name": "Sithidetphaiboon P."}, "@seq": "5", "ce:initials": "P.", "@_fa": "true", "@type": "auth", "ce:surname": "Sithidetphaiboon", "@auid": "57192095379", "ce:indexed-name": "Sithidetphaiboon P."}, {"ce:given-name": "Suebpong", "preferred-name": {"ce:given-name": "Suebpong", "ce:initials": "S.", "ce:surname": "Thanasanvimon", "ce:indexed-name": "Thanasanvimon S."}, "@seq": "6", "ce:initials": "S.", "@_fa": "true", "@type": "auth", "ce:surname": "Thanasanvimon", "@auid": "57192093513", "ce:indexed-name": "Thanasanvimon S."}, {"ce:given-name": "Virote", "preferred-name": {"ce:given-name": "Virote", "ce:initials": "V.", "ce:surname": "Sriuranpong", "ce:indexed-name": "Sriuranpong V."}, "@seq": "7", "ce:initials": "V.", "@_fa": "true", "@type": "auth", "ce:surname": "Sriuranpong", "@auid": "6603599644", "ce:indexed-name": "Sriuranpong V."}, {"ce:given-name": "Napa", "preferred-name": {"ce:given-name": "Napa", "ce:initials": "N.", "ce:surname": "Parinyanitikul", "ce:indexed-name": "Parinyanitikul N."}, "@seq": "8", "ce:initials": "N.", "@_fa": "true", "@type": "auth", "ce:surname": "Parinyanitikul", "@auid": "36554719100", "ce:indexed-name": "Parinyanitikul N."}]}, {"affiliation": {"country": "Thailand", "postal-code": "10330", "@afid": "60028190", "@country": "tha", "city": "Bangkok", "organization": [{"$": "Department of Preventive Medicine"}, {"$": "Faculty of Medicine"}, {"$": "Chulalongkorn University"}, {"$": "KingChulalongkorn Memorial Hospital"}], "affiliation-id": [{"@afid": "60028190", "@dptid": "104425693"}, {"@afid": "60022183"}], "@dptid": "104425693"}, "author": [{"ce:given-name": "Thanapoom", "preferred-name": {"ce:given-name": "Thanapoom", "ce:initials": "T.", "ce:surname": "Rattananupong", "ce:indexed-name": "Rattananupong T."}, "@seq": "3", "ce:initials": "T.", "@_fa": "true", "@type": "auth", "ce:surname": "Rattananupong", "@auid": "55514826300", "ce:indexed-name": "Rattananupong T."}, {"ce:given-name": "Poranee", "preferred-name": {"ce:given-name": "Poranee", "ce:initials": "P.", "ce:surname": "Laoitthi", "ce:indexed-name": "Laoitthi P."}, "@seq": "4", "ce:initials": "P.", "@_fa": "true", "@type": "auth", "ce:surname": "Laoitthi", "@auid": "49761574600", "ce:indexed-name": "Laoitthi P."}]}], "citation-title": "Feasibility of withholding dexamethasone premedicationfor hypersensitivity reactions associated with paclitaxeladministration", "abstracts": "Background: Premedication with dexamethasone is crucial to prevent hypersensitivity reactions (HSR) associatedwith administration of taxanes. However, high dose and prolonged exposure to dexamethasone may cause adverseeffects.Objectives: To determine the incidence of HSR in patients with early breast cancer who did or did not receivedexamethasone prophylaxis for weekly paclitaxel infusions.Methods: We retrospectively reviewed the records of a cohort of patients with early breast cancer who receivedpaclitaxel weekly from January 2012 through March 2015 at King Chulalongkorn Memorial Hospital. All patientsreceived a standard premedication protocol including dexamethasone before their first paclitaxel infusion.Dexamethasone was omitted in later cycles in some patients at the discretion of the attending physician. Dataconcerning the baseline characteristics of the patient, details of the premedication protocol, including dose andschedule of dexamethasone, and HSR events were collected in this observational study.Results: Data were drawn from 86 breast cancer patients (median age 52.6 years) treated with a total of 984 cyclesof paclitaxel chemotherapy. No patient had any history of allergy or HSR to taxanes. Dexamethasone was omittedin 617 later cycles. Six patients had grade II-III HSR (7.0%), which occurred mostly during the first 6 cycles(5/6, 83.3%). The incidence of HRS was 3/367 cycles (0.82%) with dexamethasone premedication (P = 0.99) and5/617 (0.81%) without.Conclusions: Withholding dexamethasone premedication for paclitaxel chemotherapy was feasible, and did notresult in a higher incidence of HSR. However, an optimal schedule for dexamethasone warrants investigation ina prospective manner.", "correspondence": {"affiliation": {"country": "Thailand", "postal-code": "10330", "@country": "tha", "city": "Bangkok", "organization": [{"$": "Division of Medical Oncology"}, {"$": "Department of Medicine"}, {"$": "Faculty of Medicine"}, {"$": "Chulalongkorn University"}, {"$": "King Chulalongkorn Memorial Hospital"}]}, "person": {"ce:given-name": "Napa", "ce:initials": "N.", "ce:surname": "Parinyanitikul", "ce:indexed-name": "Parinyanitikul N."}}, "citation-info": {"author-keywords": {"author-keyword": [{"$": "Dexamethasone premedication", "@xml:lang": "eng"}, {"$": "Infusion hypersensitivity reaction", "@xml:lang": "eng"}, {"$": "Paclitaxel", "@xml:lang": "eng"}]}, "citation-type": {"@code": "ar"}, "citation-language": {"@language": "English", "@xml:lang": "eng"}, "abstract-language": {"@language": "English", "@xml:lang": "eng"}}, "source": {"sourcetitle-abbrev": "Asian Biomed.", "website": {"ce:e-address": {"$": "http://abm.digitaljournals.org/index.php/abm/article/viewFile/3610/1081", "@type": "email"}}, "@country": "tha", "translated-sourcetitle": {"$": "Asian Biomedicine", "@xml:lang": "eng"}, "issn": [{"$": "1875855X", "@type": "electronic"}, {"$": "19057415", "@type": "print"}], "volisspag": {"voliss": {"@volume": "10", "@issue": "4"}, "pagerange": {"@first": "371", "@last": "377"}}, "@type": "j", "publicationyear": {"@first": "2016"}, "publisher": {"publishername": "Asian Biomedicine", "ce:e-address": {"$": "chulamed@md.chula.ac.th", "@type": "email"}}, "sourcetitle": "Asian Biomedicine", "@srcid": "19300156818", "publicationdate": {"month": "08", "year": "2016", "date-text": "August 2016", "day": "01"}}, "enhancement": {"classificationgroup": {"classifications": [{"@type": "EMCLASS", "classification": [{"classification-code": "10", "classification-description": "Obstetrics and Gynecology"}, {"classification-code": "16", "classification-description": "Cancer"}, {"classification-code": "26", "classification-description": "Immunology, Serology and Transplantation"}, {"classification-code": "37", "classification-description": "Drug Literature Index"}, {"classification-code": "38", "classification-description": "Adverse Reactions Titles"}]}, {"@type": "ASJC", "classification": "1300"}, {"@type": "SUBJABBR", "classification": "BIOC"}]}, "chemicalgroup": {"chemicals": {"@source": "esbd", "chemical": [{"cas-registry-number": "132-22-9", "chemical-name": "chlorpheniramine"}, {"cas-registry-number": "50-02-2", "chemical-name": "dexamethasone"}, {"cas-registry-number": [{"$": "147-24-0"}, {"$": "58-73-1"}], "chemical-name": "diphenhydramine"}, {"cas-registry-number": [{"$": "51-43-4"}, {"$": "55-31-2"}, {"$": "6912-68-1"}], "chemical-name": "epinephrine"}, {"cas-registry-number": "33069-62-4", "chemical-name": "paclitaxel"}, {"cas-registry-number": [{"$": "66357-35-5"}, {"$": "66357-59-3"}], "chemical-name": "ranitidine"}, {"cas-registry-number": "180288-69-1", "chemical-name": "trastuzumab"}]}}}, "grantlist": {"@complete": "y", "grant-text": {"$": "This work was supported by a RatchadaphiseksomphotResearch Grant, Faculty of Medicine, Chulalongkorn University, Grant number 63/53 andby the Ratchadaphiseksomphot Endowment Fund ofChulalongkorn University (CU-57-001-HR).", "@xml:lang": "eng"}, "grant": {"grant-acronym": "CU", "grant-agency": "Chulalongkorn University"}}}, "item-info": {"copyright": {"$": "Copyright 2017 Elsevier B.V., All rights reserved.", "@type": "Elsevier"}, "dbcollection": [{"$": "EMBASE"}, {"$": "REAXYSCAR"}, {"$": "SCOPUS"}, {"$": "Scopusbase"}], "history": {"date-created": {"@day": "02", "@timestamp": "BST 06:31:24", "@year": "2017", "@month": "01"}}, "itemidlist": {"itemid": [{"$": "613452699", "@idtype": "PUI"}, {"$": "658620598", "@idtype": "CAR-ID"}, {"$": "20160870872", "@idtype": "EMBASE"}, {"$": "20162416844", "@idtype": "REAXYSCAR"}, {"$": "84997418118", "@idtype": "SCP"}, {"$": "84997418118", "@idtype": "SGR"}], "ce:doi": "10.5372/1905-7415.1004.500"}}, "tail": {"bibliography": {"@refcount": "10", "reference": [{"ref-fulltext": "Sendo T, Sakai N, Itoh Y, Ikesue H, Kobayashi H, Hirakawa T, et al. Incidence and risk factors forpaclitaxel hypersensitivity during ovarian cancerchemotherapy. Cancer Chemother Pharmacol. 2005;56:91-6.", "@id": "1", "ref-info": {"ref-publicationyear": {"@first": "2005"}, "ref-title": {"ref-titletext": "Incidence and risk factors forpaclitaxel hypersensitivity during ovarian cancerchemotherapy"}, "refd-itemidlist": {"itemid": {"$": "21244467059", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "56"}, "pagerange": {"@first": "91", "@last": "96"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "T.", "@_fa": "true", "ce:surname": "Sendo", "ce:indexed-name": "Sendo T."}, {"@seq": "2", "ce:initials": "N.", "@_fa": "true", "ce:surname": "Sakai", "ce:indexed-name": "Sakai N."}, {"@seq": "3", "ce:initials": "Y.", "@_fa": "true", "ce:surname": "Itoh", "ce:indexed-name": "Itoh Y."}, {"@seq": "4", "ce:initials": "H.", "@_fa": "true", "ce:surname": "Ikesue", "ce:indexed-name": "Ikesue H."}, {"@seq": "5", "ce:initials": "H.", "@_fa": "true", "ce:surname": "Kobayashi", "ce:indexed-name": "Kobayashi H."}, {"@seq": "6", "ce:initials": "T.", "@_fa": "true", "ce:surname": "Hirakawa", "ce:indexed-name": "Hirakawa T."}], "et-al": null}, "ref-sourcetitle": "Cancer Chemother Pharmacol"}}, {"ref-fulltext": "Taxol injection (package insert). Princeton: Bristol-Myers Squibb Company; 2007.", "@id": "2", "ref-info": {"ref-publicationyear": {"@first": "2007"}, "refd-itemidlist": {"itemid": {"$": "84872663596", "@idtype": "SGR"}}, "ref-text": "Princeton: Bristol-Myers Squibb Company", "ref-sourcetitle": "Taxol Injection (Package Insert)"}}, {"ref-fulltext": "Sparano JA, Wang M, Martino S, Jones V, Perez EA, Saphner T, et al. Weekly paclitaxel in the adjuvanttreatment of breast cancer. N Engl J Med. 2008; 358:1663-71.", "@id": "3", "ref-info": {"ref-publicationyear": {"@first": "2008"}, "ref-title": {"ref-titletext": "Weekly paclitaxel in the adjuvanttreatment of breast cancer"}, "refd-itemidlist": {"itemid": {"$": "42249083269", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "358"}, "pagerange": {"@first": "1663", "@last": "1671"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "J.A.", "@_fa": "true", "ce:surname": "Sparano", "ce:indexed-name": "Sparano J.A."}, {"@seq": "2", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Wang", "ce:indexed-name": "Wang M."}, {"@seq": "3", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Martino", "ce:indexed-name": "Martino S."}, {"@seq": "4", "ce:initials": "V.", "@_fa": "true", "ce:surname": "Jones", "ce:indexed-name": "Jones V."}, {"@seq": "5", "ce:initials": "E.A.", "@_fa": "true", "ce:surname": "Perez", "ce:indexed-name": "Perez E.A."}, {"@seq": "6", "ce:initials": "T.", "@_fa": "true", "ce:surname": "Saphner", "ce:indexed-name": "Saphner T."}], "et-al": null}, "ref-sourcetitle": "N Engl J Med"}}, {"ref-fulltext": "Miller K, Wang M, Gralow J, Dickler M, Cobleigh M, Perez EA, et al. Paclitaxel plus bevacizumab versuspaclitaxel alone for metastatic breast cancer. N Engl JMed. 2007; 357:2666-76.", "@id": "4", "ref-info": {"ref-publicationyear": {"@first": "2007"}, "ref-title": {"ref-titletext": "Paclitaxel plus bevacizumab versuspaclitaxel alone for metastatic breast cancer"}, "refd-itemidlist": {"itemid": {"$": "37549040613", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "357"}, "pagerange": {"@first": "2666", "@last": "2676"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Miller", "ce:indexed-name": "Miller K."}, {"@seq": "2", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Wang", "ce:indexed-name": "Wang M."}, {"@seq": "3", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Gralow", "ce:indexed-name": "Gralow J."}, {"@seq": "4", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Dickler", "ce:indexed-name": "Dickler M."}, {"@seq": "5", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Cobleigh", "ce:indexed-name": "Cobleigh M."}, {"@seq": "6", "ce:initials": "E.A.", "@_fa": "true", "ce:surname": "Perez", "ce:indexed-name": "Perez E.A."}], "et-al": null}, "ref-sourcetitle": "N Engl JMed"}}, {"ref-fulltext": "K\u00f6ppler H, Heymanns J, Weide R. Dose reduction ofsteroid premedication for paclitaxel: no increase ofhypersensitivity reactions. Onkologie. 2001; 24:283-5.[Article in English, German]", "@id": "5", "ref-info": {"ref-publicationyear": {"@first": "2001"}, "ref-title": {"ref-titletext": "Dose reduction ofsteroid premedication for paclitaxel: No increase ofhypersensitivity reactions"}, "refd-itemidlist": {"itemid": {"$": "0034919877", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "24"}, "pagerange": {"@first": "283", "@last": "285"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "H.", "@_fa": "true", "ce:surname": "K\u00f6ppler", "ce:indexed-name": "Koppler H."}, {"@seq": "2", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Heymanns", "ce:indexed-name": "Heymanns J."}, {"@seq": "3", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Weide", "ce:indexed-name": "Weide R."}]}, "ref-sourcetitle": "Onkologie"}}, {"ref-fulltext": "Berger MJ, Dunlea LJ, Rettig AE, Lustberg MB, Phillips GS, Shapiro CL. Feasibility of stoppingpaclitaxel premedication after two doses in patientsnot experiencing a previous infusion hypersensitivityreaction. Support Care Cancer. 2012; 20:1991-7.", "@id": "6", "ref-info": {"ref-publicationyear": {"@first": "2012"}, "ref-title": {"ref-titletext": "Feasibility of stoppingpaclitaxel premedication after two doses in patientsnot experiencing a previous infusion hypersensitivityreaction"}, "refd-itemidlist": {"itemid": {"$": "84865174174", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "20"}, "pagerange": {"@first": "1991", "@last": "1997"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "M.J.", "@_fa": "true", "ce:surname": "Berger", "ce:indexed-name": "Berger M.J."}, {"@seq": "2", "ce:initials": "L.J.", "@_fa": "true", "ce:surname": "Dunlea", "ce:indexed-name": "Dunlea L.J."}, {"@seq": "3", "ce:initials": "A.E.", "@_fa": "true", "ce:surname": "Rettig", "ce:indexed-name": "Rettig A.E."}, {"@seq": "4", "ce:initials": "M.B.", "@_fa": "true", "ce:surname": "Lustberg", "ce:indexed-name": "Lustberg M.B."}, {"@seq": "5", "ce:initials": "G.S.", "@_fa": "true", "ce:surname": "Phillips", "ce:indexed-name": "Phillips G.S."}, {"@seq": "6", "ce:initials": "C.L.", "@_fa": "true", "ce:surname": "Shapiro", "ce:indexed-name": "Shapiro C.L."}]}, "ref-sourcetitle": "Support Care Cancer"}}, {"ref-fulltext": "Berger MJ, Vargo C, Vincent M, Shaver K, Phillips G, Layman R, et al. Stopping paclitaxel premedicationafter two doses in patients not experiencing aprevious infusion hypersensitivity reaction. SupportCare Cancer. 2015; 23:2019-24.", "@id": "7", "ref-info": {"ref-publicationyear": {"@first": "2015"}, "ref-title": {"ref-titletext": "Stopping paclitaxel premedicationafter two doses in patients not experiencing aprevious infusion hypersensitivity reaction"}, "refd-itemidlist": {"itemid": {"$": "84929943332", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "23"}, "pagerange": {"@first": "2019", "@last": "2024"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "M.J.", "@_fa": "true", "ce:surname": "Berger", "ce:indexed-name": "Berger M.J."}, {"@seq": "2", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Vargo", "ce:indexed-name": "Vargo C."}, {"@seq": "3", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Vincent", "ce:indexed-name": "Vincent M."}, {"@seq": "4", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Shaver", "ce:indexed-name": "Shaver K."}, {"@seq": "5", "ce:initials": "G.", "@_fa": "true", "ce:surname": "Phillips", "ce:indexed-name": "Phillips G."}, {"@seq": "6", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Layman", "ce:indexed-name": "Layman R."}], "et-al": null}, "ref-sourcetitle": "SupportCare Cancer"}}, {"ref-fulltext": "Piovano E, Pivetta E, Modaffari P, Martra F, BaimaPoma C, Perotto S, et al. A search for predictive factorsfor hypersensitivity reactions to paclitaxel andplatinum salts in chemotherapy for gynecologicpelvic neoplasms. Gynecol Obstet Invest. 2012; 74:21-7.", "@id": "8", "ref-info": {"ref-publicationyear": {"@first": "2012"}, "ref-title": {"ref-titletext": "A search for predictive factorsfor hypersensitivity reactions to paclitaxel andplatinum salts in chemotherapy for gynecologicpelvic neoplasms"}, "refd-itemidlist": {"itemid": {"$": "84864597197", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "74"}, "pagerange": {"@first": "21", "@last": "27"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "E.", "@_fa": "true", "ce:surname": "Piovano", "ce:indexed-name": "Piovano E."}, {"@seq": "2", "ce:initials": "E.", "@_fa": "true", "ce:surname": "Pivetta", "ce:indexed-name": "Pivetta E."}, {"@seq": "3", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Modaffari", "ce:indexed-name": "Modaffari P."}, {"@seq": "4", "ce:initials": "F.", "@_fa": "true", "ce:surname": "Martra", "ce:indexed-name": "Martra F."}, {"@seq": "5", "ce:initials": "C.", "@_fa": "true", "ce:surname": "BaimaPoma", "ce:indexed-name": "BaimaPoma C."}, {"@seq": "6", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Perotto", "ce:indexed-name": "Perotto S."}], "et-al": null}, "ref-sourcetitle": "Gynecol Obstet Invest"}}, {"ref-fulltext": "Sui M, Chen F, Chen Z, Fan W. Glucocorticoidsinterfere with therapeutic ef\u00fbcacy of paclitaxel againsthuman breast and ovarian xenograft tumors. Int JCancer. 2006; 119:712-7.", "@id": "9", "ref-info": {"ref-publicationyear": {"@first": "2006"}, "ref-title": {"ref-titletext": "Glucocorticoidsinterfere with therapeutic ef\u00fbcacy of paclitaxel againsthuman breast and ovarian xenograft tumors"}, "refd-itemidlist": {"itemid": {"$": "33745440667", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "119"}, "pagerange": {"@first": "712", "@last": "717"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Sui", "ce:indexed-name": "Sui M."}, {"@seq": "2", "ce:initials": "F.", "@_fa": "true", "ce:surname": "Chen", "ce:indexed-name": "Chen F."}, {"@seq": "3", "ce:initials": "Z.", "@_fa": "true", "ce:surname": "Chen", "ce:indexed-name": "Chen Z."}, {"@seq": "4", "ce:initials": "W.", "@_fa": "true", "ce:surname": "Fan", "ce:indexed-name": "Fan W."}]}, "ref-sourcetitle": "Int JCancer"}}, {"ref-fulltext": "Hou WJ, Guan JH, Dong Q, Han YH, Zhang R.Dexamethasone inhibits the effect of paclitaxel onhuman ovarian carcinoma xenografts in nude mice.Eur Rev Med Pharmacol Sci. 2013; 17:2902-8.", "@id": "10", "ref-info": {"ref-publicationyear": {"@first": "2013"}, "ref-title": {"ref-titletext": "Dexamethasone inhibits the effect of paclitaxel onhuman ovarian carcinoma xenografts in nude mice"}, "refd-itemidlist": {"itemid": {"$": "84891821684", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "17"}, "pagerange": {"@first": "2902", "@last": "2908"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "W.J.", "@_fa": "true", "ce:surname": "Hou", "ce:indexed-name": "Hou W.J."}, {"@seq": "2", "ce:initials": "J.H.", "@_fa": "true", "ce:surname": "Guan", "ce:indexed-name": "Guan J.H."}, {"@seq": "3", "ce:initials": "Q.", "@_fa": "true", "ce:surname": "Dong", "ce:indexed-name": "Dong Q."}, {"@seq": "4", "ce:initials": "Y.H.", "@_fa": "true", "ce:surname": "Han", "ce:indexed-name": "Han Y.H."}, {"@seq": "5", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Zhang", "ce:indexed-name": "Zhang R."}]}, "ref-sourcetitle": "Eur Rev Med Pharmacol Sci"}}]}}}}, "affiliation": {"affiliation-city": "Bangkok", "@id": "60028190", "affilname": "Chulalongkorn University", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190", "affiliation-country": "Thailand"}, "coredata": {"srctype": "j", "eid": "2-s2.0-84997418118", "dc:description": "Background: Premedication with dexamethasone is crucial to prevent hypersensitivity reactions (HSR) associatedwith administration of taxanes. However, high dose and prolonged exposure to dexamethasone may cause adverseeffects.Objectives: To determine the incidence of HSR in patients with early breast cancer who did or did not receivedexamethasone prophylaxis for weekly paclitaxel infusions.Methods: We retrospectively reviewed the records of a cohort of patients with early breast cancer who receivedpaclitaxel weekly from January 2012 through March 2015 at King Chulalongkorn Memorial Hospital. All patientsreceived a standard premedication protocol including dexamethasone before their first paclitaxel infusion.Dexamethasone was omitted in later cycles in some patients at the discretion of the attending physician. Dataconcerning the baseline characteristics of the patient, details of the premedication protocol, including dose andschedule of dexamethasone, and HSR events were collected in this observational study.Results: Data were drawn from 86 breast cancer patients (median age 52.6 years) treated with a total of 984 cyclesof paclitaxel chemotherapy. No patient had any history of allergy or HSR to taxanes. Dexamethasone was omittedin 617 later cycles. Six patients had grade II-III HSR (7.0%), which occurred mostly during the first 6 cycles(5/6, 83.3%). The incidence of HRS was 3/367 cycles (0.82%) with dexamethasone premedication (P = 0.99) and5/617 (0.81%) without.Conclusions: Withholding dexamethasone premedication for paclitaxel chemotherapy was feasible, and did notresult in a higher incidence of HSR. However, an optimal schedule for dexamethasone warrants investigation ina prospective manner.", "prism:coverDate": "2016-08-01", "prism:aggregationType": "Journal", "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/84997418118", "dc:creator": {"author": [{"ce:given-name": "Walailuk", "preferred-name": {"ce:given-name": "Walailuk", "ce:initials": "W.", "ce:surname": "Tanpipattanakul", "ce:indexed-name": "Tanpipattanakul W."}, "@seq": "1", "ce:initials": "W.", "@_fa": "true", "affiliation": {"@id": "60028190", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"}, "ce:surname": "Tanpipattanakul", "@auid": "57192099732", "author-url": "https://api.elsevier.com/content/author/author_id/57192099732", "ce:indexed-name": "Tanpipattanakul W."}]}, "link": [{"@_fa": "true", "@rel": "self", "@href": "https://api.elsevier.com/content/abstract/scopus_id/84997418118"}, {"@_fa": "true", "@rel": "scopus", "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84997418118&origin=inward"}, {"@_fa": "true", "@rel": "scopus-citedby", "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=84997418118&origin=inward"}], "source-id": "19300156818", "citedby-count": "1", "prism:volume": "10", "subtype": "ar", "dc:title": "Feasibility of withholding dexamethasone premedicationfor hypersensitivity reactions associated with paclitaxeladministration", "openaccess": "1", "prism:issn": "1875855X 19057415", "prism:issueIdentifier": "4", "subtypeDescription": "Article", "prism:publicationName": "Asian Biomedicine", "prism:pageRange": "371-377", "prism:endingPage": "377", "openaccessFlag": "true", "prism:doi": "10.5372/1905-7415.1004.500", "prism:startingPage": "371", "dc:identifier": "SCOPUS_ID:84997418118", "dc:publisher": "Asian Biomedicinechulamed@md.chula.ac.th"}, "idxterms": null, "language": {"@xml:lang": "eng"}, "authkeywords": {"author-keyword": [{"@_fa": "true", "$": "Dexamethasone premedication"}, {"@_fa": "true", "$": "Infusion hypersensitivity reaction"}, {"@_fa": "true", "$": "Paclitaxel"}]}, "subject-areas": {"subject-area": [{"@_fa": "true", "$": "Biochemistry, Genetics and Molecular Biology (all)", "@code": "1300", "@abbrev": "BIOC"}]}, "authors": {"author": [{"ce:given-name": "Walailuk", "preferred-name": {"ce:given-name": "Walailuk", "ce:initials": "W.", "ce:surname": "Tanpipattanakul", "ce:indexed-name": "Tanpipattanakul W."}, "@seq": "1", "ce:initials": "W.", "@_fa": "true", "affiliation": {"@id": "60028190", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"}, "ce:surname": "Tanpipattanakul", "@auid": "57192099732", "author-url": "https://api.elsevier.com/content/author/author_id/57192099732", "ce:indexed-name": "Tanpipattanakul W."}, {"ce:given-name": "Nattaya", "preferred-name": {"ce:given-name": "Nattaya", "ce:initials": "N.", "ce:surname": "Poovorawan", "ce:indexed-name": "Poovorawan N."}, "@seq": "2", "ce:initials": "N.", "@_fa": "true", "affiliation": {"@id": "60028190", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"}, "ce:surname": "Poovorawan", "@auid": "57192107420", "author-url": "https://api.elsevier.com/content/author/author_id/57192107420", "ce:indexed-name": "Poovorawan N."}, {"ce:given-name": "Thanapoom", "preferred-name": {"ce:given-name": "Thanapoom", "ce:initials": "T.", "ce:surname": "Rattananupong", "ce:indexed-name": "Rattananupong T."}, "@seq": "3", "ce:initials": "T.", "@_fa": "true", "affiliation": {"@id": "60028190", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"}, "ce:surname": "Rattananupong", "@auid": "55514826300", "author-url": "https://api.elsevier.com/content/author/author_id/55514826300", "ce:indexed-name": "Rattananupong T."}, {"ce:given-name": "Poranee", "preferred-name": {"ce:given-name": "Poranee", "ce:initials": "P.", "ce:surname": "Laoitthi", "ce:indexed-name": "Laoitthi P."}, "@seq": "4", "ce:initials": "P.", "@_fa": "true", "affiliation": {"@id": "60028190", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"}, "ce:surname": "Laoitthi", "@auid": "49761574600", "author-url": "https://api.elsevier.com/content/author/author_id/49761574600", "ce:indexed-name": "Laoitthi P."}, {"ce:given-name": "Piyada", "preferred-name": {"ce:given-name": "Piyada", "ce:initials": "P.", "ce:surname": "Sithidetphaiboon", "ce:indexed-name": "Sithidetphaiboon P."}, "@seq": "5", "ce:initials": "P.", "@_fa": "true", "affiliation": {"@id": "60028190", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"}, "ce:surname": "Sithidetphaiboon", "@auid": "57192095379", "author-url": "https://api.elsevier.com/content/author/author_id/57192095379", "ce:indexed-name": "Sithidetphaiboon P."}, {"ce:given-name": "Suebpong", "preferred-name": {"ce:given-name": "Suebpong", "ce:initials": "S.", "ce:surname": "Thanasanvimon", "ce:indexed-name": "Thanasanvimon S."}, "@seq": "6", "ce:initials": "S.", "@_fa": "true", "affiliation": {"@id": "60028190", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"}, "ce:surname": "Thanasanvimon", "@auid": "57192093513", "author-url": "https://api.elsevier.com/content/author/author_id/57192093513", "ce:indexed-name": "Thanasanvimon S."}, {"ce:given-name": "Virote", "preferred-name": {"ce:given-name": "Virote", "ce:initials": "V.", "ce:surname": "Sriuranpong", "ce:indexed-name": "Sriuranpong V."}, "@seq": "7", "ce:initials": "V.", "@_fa": "true", "affiliation": {"@id": "60028190", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"}, "ce:surname": "Sriuranpong", "@auid": "6603599644", "author-url": "https://api.elsevier.com/content/author/author_id/6603599644", "ce:indexed-name": "Sriuranpong V."}, {"ce:given-name": "Napa", "preferred-name": {"ce:given-name": "Napa", "ce:initials": "N.", "ce:surname": "Parinyanitikul", "ce:indexed-name": "Parinyanitikul N."}, "@seq": "8", "ce:initials": "N.", "@_fa": "true", "affiliation": {"@id": "60028190", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"}, "ce:surname": "Parinyanitikul", "@auid": "36554719100", "author-url": "https://api.elsevier.com/content/author/author_id/36554719100", "ce:indexed-name": "Parinyanitikul N."}]}}}